Oligonucleotide Manufacturing CDMOs in Asia-Pacific
9 published
9 published CDMOs match Oligonucleotide Manufacturing in Asia-Pacific.
Locations in this set include United States, United Kingdom, China, India, Japan, and Singapore.
Capabilities that show up most often in this set: Oligonucleotide, Peptide, Small Molecule, Biologics (Other), and Antibody-Drug Conjugate (ADC).
Matching companies
Ajinomoto Bio-Pharma ServicesAjinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.
Almac GroupGlobal CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.
BachemGlobal leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.
Global Biotech LaboratoriesGlobal Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents.
HitGen Inc.HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
PortonPorton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
Sapala OrganicsCustom synthesis of nucleic acid building blocks, modified phosphoramidites and oligonucleotide delivery compounds, plus FTE-based CRO and fee-for-service CDMO engagements. Orthogonal analytical services serve clients from early R&D through pharma innovators.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /services/oligonucleotide-manufacturing/apac.md